These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9454244)
1. [Specific features of pulmonary tuberculosis course in patients with insulin-dependent diabetes mellitus in relation to a varying HLA phenotype]. Karachunskií MA; Komliakova EG; Pospelov LE Probl Tuberk; 1997; (5):23-5. PubMed ID: 9454244 [TBL] [Abstract][Full Text] [Related]
2. [Epidemiological and immunogenetic analysis of tuberculosis and diabetes mellitus association]. Chukanova VP; Sergeev AS; Pospelov LE; Sobkin AL Probl Tuberk; 2000; (4):11-4. PubMed ID: 10981422 [TBL] [Abstract][Full Text] [Related]
3. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus]. Karachunskiĭ MA; Gergert VIa; Iakovleva OB Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939 [TBL] [Abstract][Full Text] [Related]
5. [Class I and II antigens and levels of IgG antibodies in patients with infiltrative tuberculosis of the lungs]. Nikolaian LT; Karapetian ET; Pospelov LE Probl Tuberk; 1989; (3):49-51. PubMed ID: 2786199 [TBL] [Abstract][Full Text] [Related]
6. [Pulmonary tuberculosis in patients with different types of diabetes mellitus]. Kossiĭ IuE; Karachunskiĭ MA; Kaminskaia GO; Chernykh NA; Zhukovskaia DE Probl Tuberk; 2002; (5):21-4. PubMed ID: 12164113 [TBL] [Abstract][Full Text] [Related]
7. [The specific features of the course of pulmonary tuberculosis in young Tuvinians in relation to some antigens of the HLA complex]. Kyzyl-Oll MM; Pospelov AL; Kordicheva SIu; Soroko-Novitskaia AN; Pospelov LE; Mishin VIu Tuberk Biolezni Legkih; 2009; (12):53-7. PubMed ID: 20095374 [TBL] [Abstract][Full Text] [Related]
8. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus]. Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557 [TBL] [Abstract][Full Text] [Related]
10. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
11. [Current aspects of the antitubercular chemotherapy of new patients with tuberculosis and diabetes mellitus]. Ghinescu V; Mihălţan F; Chiotan D Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):115-26. PubMed ID: 2555896 [TBL] [Abstract][Full Text] [Related]
12. [The results of treating fibrous-cavernous tuberculosis in patients with different genetic markers]. Khomenko AG; Sadykov AS Ter Arkh; 1990; 62(11):53-6. PubMed ID: 2094991 [TBL] [Abstract][Full Text] [Related]
13. [Tactics of diabetes mellitus compensation in patients with pulmonary tuberculosis]. Karachunskiĭ MA; Fedorova VI; Beglarian NR; Iakovleva OB Probl Tuberk; 1991; (11):55-7. PubMed ID: 1775465 [No Abstract] [Full Text] [Related]
14. [HLA genes in patients with pulmonary tuberculosis in the Kirghiz population]. Alisherov AS; Kitaev MI; Tarasenko OM; Tiurebaeva BN Probl Tuberk; 1997; (5):41-2. PubMed ID: 9454253 [TBL] [Abstract][Full Text] [Related]
16. [Distribution of histocompatibility antigens in patients with pulmonary tuberculosis depending on disease course and immune response pattern]. Knoring BE; Berkos AS; Sakharova IIa Probl Tuberk; 1995; (2):16-9. PubMed ID: 7777453 [TBL] [Abstract][Full Text] [Related]
17. [Clinical symptoms and course of pulmonary tuberculosis in patients with various types of diabetes mellitus]. Karachunskiĭ MA; Kossiĭ IuE; Iakovleva OB Probl Tuberk; 1993; (4):20-1. PubMed ID: 8127828 [TBL] [Abstract][Full Text] [Related]